| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC3436 | |||||||||||||||||||||||
| Submitter : | Mr. Gregory Werner | Date & Time: | 12/18/2006 09:12:11 | |||||||||||||||||||||
| Organization : | Mr. Gregory Werner | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| There can not be use of aborted fetal cells in such creation of vaccinaations. Viable alternatives exists, which make such technology unnecessary. The destruction of human life for scientific gain must never be taken lightly, and in this case, human life would be destroyed unnecessarily | ||||||||||||||||||||||||